Alt tag

MEDRAD® Centargo

Alt tag
Alt tag

Enhance Your Daily Practice with Bayer

Ultravist® in combination with MEDRAD® Centargo supports you in achieving diagnostic image quality

Learn More About Ultravist®

Optimized Workflow

Optimizing Operations & Elevating Care

Alt tag

In-built weight-based dosing algorithm & kVp modulation dosing capability

Did you know...

MEDRAD® Centargo is the only injector…

Alt tag

Multi-patient, piston-based CT injector in Canada capable of reaching 300 psi.

Alt tag

5 detectors for air monitoring plus an automatic air removal procedure.

Alt tag

Automatically refills resevoirs and has an automated patient line priming function

Alt tag

Can help sites save up to 23 minutes a day*

* Calculations are based on a site that scans on average 30 patients per day, following the values outlined in PerCent Study.

Alt tag

Contrast Enhanced Mammography

MEDRAD® Centargo – Your Efficient Partner in CE Mammography

Contrast Enhanced Mammography is a fast-growing technique for breast cancer detection and diagnosis. It uses iodinated contrast media and dual energy digital mammography to produce a recombined image of the breast that shows areas of contrast enhancement.

The MEDRAD® Centargo helps technologists new to the practice of injecting contrast to navigate through a new workflow with ease. Through its user intuitiveness and automation of manual processes, MEDRAD® Centargo can help technologists streamline their workflow in busy breast assessment practices.

Alt tag
Alt tag

Service Offerings

We’re Here to Help

We provide different service options that cater to your needs. Learn more about CT injector service offerings.

Learn More

Talk to Our Team

To learn more about MEDRAD® Centargo or other Bayer Radiology solutions.

Contact Us
Alt tag
Alt tag

Complaints related to Radiology/MEDRAD devices or disposables should be reported to ricustomercomplaints@bayer.com.

References:

  1. Hendriks BMF et al. Optimizing Pulmonary Embolism Computed Tomography in the Age of Individualized Medicine: A Prospective Clinical Study. Invest Radiol. 2018;53(5):306-312.